Cengild Medical Berhad Valuation

Q: What is the Fair Price of CENGILD when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

CENGILD (MYR0.27) is trading above our estimate of [[fair value]] (MYR0.15)

Is CENGILD undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of CENGILD when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: CENGILD (MYR0.27) is trading above our estimate of fair value (MYR0.15)

Significantly Below Fair Value: CENGILD is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for CENGILD?

Key metric: As CENGILD is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for CENGILD. This is calculated by dividing CENGILD's market cap by their current earnings.
What is CENGILD's PE Ratio?
PE Ratio	20.3x
Earnings	RM 11.08m
Market Cap	RM 224.89m

CENGILD key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	2.1x
Enterprise Value/EBITDA	9.6x
PEG Ratio	n/a

Price to Earnings Ratio vs Peers

How does CENGILD's PE Ratio compare to its peers?

The above table shows the PE ratio for CENGILD vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	24.3x
FOCUSP Focus Point Holdings Berhad	10.9x	10.9%	RM 374.2m
UMC UMediC Group Berhad	25.2x	23.8%	RM 226.2m
METRO Metro Healthcare Berhad	28.3x	n/a	RM 185.0m
KPJ KPJ Healthcare Berhad	32.8x	8.7%	RM 10.0b
CENGILD Cengild Medical Berhad	20.3x	n/a	RM 224.9m

Price-To-Earnings vs Peers: CENGILD is good value based on its Price-To-Earnings Ratio (20.3x) compared to the peer average (24.3x).

Price to Earnings Ratio vs Industry

How does CENGILD's PE Ratio compare vs other companies in the Asian Healthcare Industry?

2 Companies	Price / Earnings	Estimated Growth	Market Cap

2 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Earnings vs Industry: CENGILD is good value based on its Price-To-Earnings Ratio (20.3x) compared to the Asian Healthcare industry average (20.8x).

Price to Earnings Ratio vs Fair Ratio

What is CENGILD's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

CENGILD PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	20.3x
Fair PE Ratio	n/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate CENGILD's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.